Portal de Periódicos da CAPES

Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)

2023; Adis, Springer Healthcare; Volume: 14; Issue: 7 Linguagem: Inglês

10.1007/s13300-023-01417-1

1869-6961

Cristina Tejera Pérez, Ana Chico, Sharona Azriel-Mira, Beatriz Lardiés‐Sánchez, Fernando Gómez-Peralta, Amor Fernández Antonio Jesús, Bartual Rodrigo Amparo, Virginia Bellido, Bellido Guerrero Diego, Botana López Manuel Antonio, Brito Sanfiel Miguel, C. Gloria, Cepero Garcia Daniel, C. Ana, Conget Donlo Ignacio, de Luis Román Daniel Antonio, Durán Martínez María, Duran Rodriguez-Hervada Alejandra, Javier Escaned, F. Carlos, Fernández García Diego, García Fernández Elena, García Jiménez Custodia, Gargallo Fernández Manuel, Gómez Peralta Fernando, González Blanco Cintia, González Clemente José Miguel, González Pérez De Villar Noemí, Gros Herguido Noelia, Hernandez Martinez Antonio Miguel, Herranz Antolin Sandra, Esteban Jódar, Lardiés Sánchez Beatriz, Lecumberri Pascual Edurne, L Martin, López Fernández Judith, López Gallardo Gema, Marco Martinez Amparo, Márquez Pardo Rosa, Merino Torres Juan Francisco, Mezquita Raya Pedro, Mira Sharona, Morales Portillo Cristóbal, M Oscar, Muñoz Torres Manuel, Pablos Velasco Pedro Luis De, Pinés Corrales Pedro José, Quílez Toboso Rosa Pilar, Reyes García Rebeca, Rozas Moreno Pedro, Rodríguez Carnero María Gemma, Tejera Pérez Cristina,

Pancreatic function and diabetes

Undoubtedly, technological advances have revolutionised diabetes management in recent years. The development of advanced closed hybrid loop insulin pumps or continuous glucose monitoring (CGM) systems, among others, have increased the quality of life and improved glycaemic control of people with diabetes. However, only some patients have access to such technology, and only some want to use it. CGM has become much more widespread, but in terms of insulin delivery, most people with type 1 diabetes (T1D) and almost all people with type 2 diabetes (T2D) on insulin therapy are treated with multiple-dose insulin injections (MDI) rather than an insulin pump. For these patients, using connected insulin pens or caps has shown benefits in reducing missed insulin injections and promoting correct administration over time. In addition, using these devices improves the quality of life and user satisfaction. The integration of insulin injection and CGM data facilitates both users and the healthcare team to analyse glucose control and implement appropriate therapeutic changes, reducing therapeutic inertia. This expert's recommendation reviews the characteristics of the devices marketed or in the process of being marketed and their available scientific evidence. Finally, it suggests the profile of users and professionals who would benefit most, the barriers to its generalisation and the changes in the care model that implementing these devices can bring with it.